{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:41:23Z","timestamp":1791024083763,"version":"4.1.0"},"reference-count":54,"publisher":"Wiley","issue":"2-3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2006,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>For the last 25 years, haematopoietic cell transplantation (HCT) has been used as effective therapy for selected inborn errors of metabolism (IEMs), mainly lysosomal storage diseases and peroxisomal disorders. The main rational for HCT in IEMs is based on the provision of correcting enzymes by donor cells within and outside the blood compartment. The ultimate goal of HCT is to achieve a normal or near\u2010normal life and normal neurodevelopment. HCT has been performed for more than 20 diseases. Only for Hurler syndrome, X\u2010ALD and infantile Krabbe disease, are detailed studies available suggesting that HCT is indicated for carefully selected cases. Improvement of transplantation techniques and alternative therapies may change the recommended (contra\u2010)indications for IEM. A recent example of emerging transplantation techniques is the fast availability of unrelated cord blood (UCB). UCB makes HCT feasible in patients with rapidly progressive neurological diseases. Because of the fast availability of UCB and therefore the ability to transplant shortly after diagnosis, there is no indication for patients in a moderate\/good clinical condition to receive enzyme replacement therapy (ERT; in Hurler syndrome) prior to or during HCT and can ERT only be considered in patients with poor clinical condition. Mesenchymal stem cell infusions with HCT is an emerging technique, and might be interesting in halting the remaining defects after successful HCT. Improvement in HCT techniques and novel stem cell sources will significantly impact the safety and efficacy of this therapy as well as expand the list of candidate disorders. A good functioning worldwide registry would be necessary to measure the effects of the procedures performed in more detail.<\/jats:p>","DOI":"10.1007\/s10545-005-0258-8","type":"journal-article","created":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T03:09:10Z","timestamp":1149822550000},"page":"413-420","source":"Crossref","is-referenced-by-count":92,"title":["Trends in haematopoietic cell transplantation for inborn errors of metabolism"],"prefix":"10.1002","volume":"29","author":[{"given":"Jaap Jan","family":"Boelens","sequence":"first","affiliation":[{"name":"Department of Immunology\/BMT UMC Utrecht\/Wilhelmina Children's Hospital  Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006283222607"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4125"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","unstructured":"BoelensJJ WynnR O'MearaA et al (2005a)Results of haematopoietic stem cell transplantation (HSCT) for Hurler's syndrome: european experience 1994\u20132004.ASH 2005 (Atlanta) Abstract no. 402..","DOI":"10.1182\/blood.V106.11.402.402"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"BoelensJJ WynnR WraithE etal (2005b)Safety and efficacy of enzyme replacement therapy (ERT) in combination with haematopoietic stem cell transplantation (HSCT) for Hurler's syndrome: European experience 2003\u20132005.ASH 2005 (Atlanta)Abstract no. 5307..","DOI":"10.1182\/blood.V106.11.5307.5307"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01999-3"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2004.1.354"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.2.303"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.6.901"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042604"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.64.1.360"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2004.01.002"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)91046-1"},{"key":"e_1_2_1_14_1","first-page":"S176","article-title":"Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marow transplantation and successful engraftment","volume":"15","author":"Klein KA","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.8.1738"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(99)00101-0"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703650"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705189"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412203112504"},{"key":"e_1_2_1_20_1","first-page":"S182","article-title":"Survival in Hurler's disease following bone marrow transplantation in 84 patients","volume":"15","author":"Krivit W","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/096368979500400409"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804163381605"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","unstructured":"KurtzbergJ KrivitW(2004)Cord blood transplantation for lysosomal storage diseases demonstrates the potential of cord blood cells for future cellular therapies.Blood (ASH meeting) Abstract no. 3602..","DOI":"10.1182\/blood.V104.11.3602.3602"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041276"},{"key":"e_1_2_1_26_1","first-page":"S185","article-title":"Treatment of severe acute graft\u2010versus\u2010host disease with third party haploidentical mesenchymal stem cells","volume":"33","author":"Le Blanc K","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"e_1_2_1_27_1","first-page":"1761","article-title":"Adrenoleukodystrophy \u2014 a scoring method for brain MR observations","volume":"15","author":"Loes DJ","year":"1994","journal-title":"Am J Neuroradiol"},{"issue":"9","key":"e_1_2_1_28_1","first-page":"1767","article-title":"Childhood cerebral form of adrenoleukodystrophy \u2014 short\u2010term effect of bone\u2010marrow transplantation on brain MR observations","volume":"15","author":"Loes DJ","year":"1994","journal-title":"Am J Neuroradiol"},{"issue":"6","key":"e_1_2_1_29_1","first-page":"1003","article-title":"Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow\u2010transplantation","volume":"17","author":"Malm G","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.8.1485"},{"key":"e_1_2_1_31_1","first-page":"3257","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Moser HW","year":"2001"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9072-3_47"},{"issue":"3","key":"e_1_2_1_33_1","first-page":"202","article-title":"The role of mesenchymal stem cells in immune modulation and haematopoietic engraftment","volume":"33","author":"Nauta AJ","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"e_1_2_1_34_1","first-page":"3421","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Neufeld EF","year":"2001"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470987070.ch107"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703839"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.7.2601"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70170-2"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3402"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041469"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704839"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.7.1679.1679"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.22.10119"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00710053"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02629-5"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704105"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032613"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(89)32795-3"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01800232"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00798216"},{"issue":"11","key":"e_1_2_1_52_1","first-page":"665A","article-title":"Unrelated donor umbilical cord blood transplantation (UD\u2010UCBT) in 92 patients at the University of Minnesota: analysis of risk factors","volume":"98","author":"Wagner JE","year":"2001","journal-title":"Blood"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70237-9"},{"key":"e_1_2_1_54_1","first-page":"3669","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Wenger DA","year":"2001"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701141"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-005-0258-8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-005-0258-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:09:32Z","timestamp":1694768972000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-005-0258-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":54,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["10.1007\/s10545-005-0258-8"],"URL":"https:\/\/doi.org\/10.1007\/s10545-005-0258-8","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}